These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38499448)

  • 1. Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro.
    Najafi D; Siri G; Sadri M; Yazdani O; Esbati R; Karimi P; Keshavarz A; Mehmandar-Oskuie A; Ilktac M
    Biotechnol Appl Biochem; 2024 Aug; 71(4):809-816. PubMed ID: 38499448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-MEG3 inhibits proliferation and metastasis by regulating miRNA-21 in gastric cancer.
    Dan J; Wang J; Wang Y; Zhu M; Yang X; Peng Z; Jiang H; Chen L
    Biomed Pharmacother; 2018 Mar; 99():931-938. PubMed ID: 29710493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.
    Zhou X; Ji G; Ke X; Gu H; Jin W; Zhang G
    Dig Dis Sci; 2015 Nov; 60(11):3271-82. PubMed ID: 26233544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression.
    Peng W; Si S; Zhang Q; Li C; Zhao F; Wang F; Yu J; Ma R
    J Exp Clin Cancer Res; 2015 Aug; 34(1):79. PubMed ID: 26253106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
    Ji L; Li X
    J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
    Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
    J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA MEG3 inhibits pituitary tumor development by participating in cell proliferation, apoptosis and EMT processes.
    Wang X; Li X; Wang Z
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D; Lu X
    Bioengineered; 2021 Dec; 12(1):225-239. PubMed ID: 33371778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis.
    Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1.
    Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S
    J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silence of MEG3 intensifies lipopolysaccharide-stimulated damage of human lung cells through modulating miR-4262.
    Li X; Zhang Q; Yang Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2369-2378. PubMed ID: 31184231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.
    Wang L; Yu M; Zhao S
    J Cell Biochem; 2019 Oct; 120(10):17709-17722. PubMed ID: 31161607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of Long Non-coding RNA LINC01106 Represses Malignant Behaviors of Gastric Cancer Cells by Targeting miR-34a-5p/MYCN Axis.
    Hong S; Li Q; Yang Y; Jing D; Zhu F
    Mol Biotechnol; 2022 Feb; 64(2):144-155. PubMed ID: 34550549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell.
    Wang Y; Kong D
    J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Meaningful Function of the Emerging Clinical Targets-lncRNA MEG3 in Gastric Cancer.
    Zhang Y; Wang Y; Jiang Y; Bai H; Wen Y
    Curr Pharm Des; 2023; 29(28):2204-2212. PubMed ID: 37846125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylated long noncoding RNA MEG3 promotes the progression of gastric cancer.
    Ding L; Tian Y; Wang L; Bi M; Teng D; Hong S
    Aging (Albany NY); 2019 Oct; 11(19):8139-8155. PubMed ID: 31584879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.
    Long J; Pi X
    Biomed Res Int; 2018; 2018():2086564. PubMed ID: 29808164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA MEG3 suppresses cell proliferation, migration and invasion, induces apoptosis and paclitaxel-resistance via miR-4513/PBLD axis in breast cancer cells.
    Zhu M; Wang F; Mi H; Li L; Wang J; Han M; Gu Y
    Cell Cycle; 2020 Dec; 19(23):3277-3288. PubMed ID: 33121324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lncRNA PVT1 silencing inhibits gastric cancer cells' progression via enhancing chemosensitivity to paclitaxel.
    Naseri B; Farsad-Akhtar N; Mardi A; Baghbani E; Bornedeli S; Asadi M; Shanehbandi D
    Gene; 2025 Jan; 932():148900. PubMed ID: 39209180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.